UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model

Human molecular genetics, 2019-10, Vol.28 (19), p.3175-3187

2019

Volltextzugriff (PDF)

Cdk5 inhibitory peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage

PloS one, 2013-09, Vol.8 (9), p.e63332-e63332

2013

Volltextzugriff (PDF)

A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice

The FASEB journal, 2013-01, Vol.27 (1), p.174-186

2013

Volltextzugriff (PDF)

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway

Molecular biology of the cell, 2012-08, Vol.23 (15), p.2856-2866

2012

Volltextzugriff (PDF)

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis

PloS one, 2016-08, Vol.11 (8), p.e0160252-e0160252

2016

Volltextzugriff (PDF)

Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation

Journal of neurovirology, 2013-10, Vol.19 (5), p.418-431

2013

Volltextzugriff (PDF)

Quantum capacitance-limited MoS2 biosensors enable remote label-free enzyme measurements

Nanoscale, 2019-09, Vol.11 (33), p.15622-15632

2019

Volltextzugriff (PDF)

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11733

2023

Volltextzugriff (PDF)

A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation

The Journal of biological chemistry, 2010-10, Vol.285 (44), p.34202-34212

2010

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 5 Modulates the Transcriptional Activity of the Mineralocorticoid Receptor and Regulates Expression of Brain-Derived Neurotrophic Factor

Molecular endocrinology (Baltimore, Md.), 2010-05, Vol.24 (5), p.941-952

2010

Volltextzugriff (PDF)

The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35

Molecular biology of the cell, 2016-11, Vol.27 (21), p.3221-3232

2016

Volltextzugriff (PDF)

Phosphorylation of the Transient Receptor Potential Ankyrin 1 by Cyclin-dependent Kinase 5 affects Chemo-nociception

Scientific reports, 2018-01, Vol.8 (1), p.1177-12, Article 1177

2018

Volltextzugriff (PDF)

TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity

Journal of Alzheimer's disease, 2014-01, Vol.39 (4), p.899

2014

Volltextzugriff (PDF)

Quantum capacitance-limited MoS 2 biosensors enable remote label-free enzyme measurements

Nanoscale, 2019-09, Vol.11 (33), p.15622-15632

2019

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 5 Phosphorylation of Human Septin SEPT5 (hCDCrel-1) Modulates Exocytosis

The Journal of neuroscience, 2008-04, Vol.28 (14), p.3631-3643

2008

Volltextzugriff (PDF)

Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration

Cellular and molecular neurobiology, 2009-12, Vol.29 (8), p.1073-1080

2009

Volltextzugriff (PDF)

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma

Cancers, 2020-07, Vol.12 (7), p.1935

2020

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 5 Differentially Regulates the Transcriptional Activity of the Glucocorticoid Receptor through Phosphorylation: Clinical Implications for the Nervous System Response to Glucocorticoids and Stress

Molecular endocrinology (Baltimore, Md.), 2007-07, Vol.21 (7), p.1552-1568

2007

Volltextzugriff (PDF)

Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases

Journal of Alzheimer's disease, 2016-09, Vol.54 (2), p.525

2016

Volltextzugriff (PDF)

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration

Histochemistry and cell biology, 2013-07, Vol.140 (1), p.23-32

2013

Volltextzugriff (PDF)

Peripheral and orofacial pain sensation is unaffected by the loss of p39

Molecular pain, 2017-01, Vol.13, p.1744806917737205-1744806917737205

2017

Volltextzugriff (PDF)

Pin1-dependent Prolyl Isomerization Modulates the Stress-induced Phosphorylation of High Molecular Weight Neurofilament Protein

The Journal of biological chemistry, 2008-09, Vol.283 (39), p.26737-26747

2008

Volltextzugriff (PDF)

Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments

Neurobiology of aging, 2011-11, Vol.32 (11), p.2016-2029

2011

Volltextzugriff (PDF)

Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein

Journal of Alzheimer's disease, 2015-10, Vol.48 (4), p.1009

2015

Volltextzugriff (PDF)

Activation of Cyclin-Dependent Kinase 5 Mediates Orofacial Mechanical Hyperalgesia

Molecular pain, 2013-12, Vol.9 (1), p.66-66

2013

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(71)
Buchkapitel
(2)

Sprache

Englisch
(72)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(48)
Animals
(38)
Phosphorylation
(33)
Humans
(27)
Cyclin-Dependent Kinase 5 - Metabolism
(23)
Biochemistry & Molecular Biology
(20)
Cyclin-Dependent Kinase 5
(20)
Mice
(20)
Neurosciences
(20)
Neurosciences & Neurology
(20)
Cdk5
(19)
Nerve Tissue Proteins - Metabolism
(18)
Rats
(16)
Neurons - Metabolism
(15)
Amino Acid Sequence
(13)
Cells, Cultured
(13)
Cyclin-Dependent Kinase 5 - Genetics
(13)
Nerve Tissue Proteins - Genetics
(13)
Cell Biology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model

Cdk5 inhibitory peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage

A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis

Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation

Quantum capacitance-limited MoS2 biosensors enable remote label-free enzyme measurements

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma

A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation

Cyclin-Dependent Kinase 5 Modulates the Transcriptional Activity of the Mineralocorticoid Receptor and Regulates Expression of Brain-Derived Neurotrophic Factor

The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35

Phosphorylation of the Transient Receptor Potential Ankyrin 1 by Cyclin-dependent Kinase 5 affects Chemo-nociception

TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity

Quantum capacitance-limited MoS 2 biosensors enable remote label-free enzyme measurements

Cyclin-Dependent Kinase 5 Phosphorylation of Human Septin SEPT5 (hCDCrel-1) Modulates Exocytosis

Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma

Cyclin-Dependent Kinase 5 Differentially Regulates the Transcriptional Activity of the Glucocorticoid Receptor through Phosphorylation: Clinical Implications for the Nervous System Response to Glucocorticoids and Stress

Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration

Peripheral and orofacial pain sensation is unaffected by the loss of p39

Pin1-dependent Prolyl Isomerization Modulates the Stress-induced Phosphorylation of High Molecular Weight Neurofilament Protein

Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments

Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein

Activation of Cyclin-Dependent Kinase 5 Mediates Orofacial Mechanical Hyperalgesia

Suchergebnisse filtern